ETFs: Drug Pricing Policy Shapes PPH Risks in 2026
The VanEck PPH ETF faces two key risks in 2026: heavy concentration in Eli Lilly and shifting U.S. drug pricing polic...
Examine the tax effects of rebalancing a portfolio and practical ways to minimize tax impact. This intro covers common scenarios and planning ideas.
21,738 articlesThe VanEck PPH ETF faces two key risks in 2026: heavy concentration in Eli Lilly and shifting U.S. drug pricing polic...
IonQ is moving from early-stage hardware to recurring cloud access and software tools. This article breaks down what ...
SoundHound posted revenue gains for the quarter, yet earnings slipped as acquisition-related costs weighed on results...
Is UPS stock a long-term winner? This guide breaks down the turnaround story, real numbers, and a clear plan for eval...
A wave of AI compute demand is reshaping the chip landscape. While Cerebras eyes an IPO, the market shows that strong...
Investors are watching Summit Midstream (SMC) 2026 Q1 earnings for clues on cash flow, debt, and future distributions...
A small-cap AI marketing platform is selling at $0.91 per share in a Reg A+ offering, aiming to replicate early tech ...
A senior Blackstone executive has become a LinkedIn sensation through a running-video series that blends leadership l...
Westport's Q4 2025 earnings release offers clues about growth, margins, and cash flow. This article breaks down the t...
When a heavyweight like SPGI outperforms in a quiet market, it often signals more than a single stock move. This piec...
As AI accelerates, investors wonder if Nvidia can hit a six-trillion milestone. This guide weighs the math, current m...
A rare stock market signal has flashed again, marking the ninth occurrence since 1950. Goldman Sachs says the readout...